WO2009105507A3 - Béloxépine, ses énantiomères et certains de leurs analogues convenant au traitement de la douleur - Google Patents
Béloxépine, ses énantiomères et certains de leurs analogues convenant au traitement de la douleur Download PDFInfo
- Publication number
- WO2009105507A3 WO2009105507A3 PCT/US2009/034461 US2009034461W WO2009105507A3 WO 2009105507 A3 WO2009105507 A3 WO 2009105507A3 US 2009034461 W US2009034461 W US 2009034461W WO 2009105507 A3 WO2009105507 A3 WO 2009105507A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beloxepin
- enantiomers
- analogs
- pain
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010547737A JP2011512414A (ja) | 2008-02-19 | 2009-02-19 | 疼痛を処置するための、ベロキセピン、その鏡像異性体および類似体 |
EP09712730A EP2285818A4 (fr) | 2008-02-19 | 2009-02-19 | Béloxépine, ses énantiomères et certains de leurs analogues convenant au traitement de la douleur |
BRPI0908098-8A BRPI0908098A2 (pt) | 2008-02-19 | 2009-02-19 | Beloxepina, composição, métodos para tratar dor em um mamífero, para inibir a recaptação de ne, para antagonizar um receptor de 5ht2 e para tratar um distúrbio em um paciente que é responsivo ao tratamento com um composto nri e com um composto antagonista de 5ht2 |
AU2009215541A AU2009215541A1 (en) | 2008-02-19 | 2009-02-19 | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
CN2009801138213A CN102007139A (zh) | 2008-02-19 | 2009-02-19 | 用于治疗疼痛的贝洛塞平、its对映体及其类似物 |
NZ594937A NZ594937A (en) | 2008-02-19 | 2009-02-19 | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
NZ587896A NZ587896A (en) | 2008-02-19 | 2009-02-19 | Enantiomers of beloxepin, and the use of beloxepin and its enantiomers to treat pain and other disorders |
MX2010009110A MX2010009110A (es) | 2008-02-19 | 2009-02-19 | Beloxepina, sus enantiomeros, y analogos de la misma para el tratamiento de dolor. |
CA2715192A CA2715192A1 (fr) | 2008-02-19 | 2009-02-19 | Beloxepine, ses enantiomeres et certains de leurs analogues convenant au traitement de la douleur |
IL207668A IL207668A0 (en) | 2008-02-19 | 2010-08-18 | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2991308P | 2008-02-19 | 2008-02-19 | |
US2991508P | 2008-02-19 | 2008-02-19 | |
US2991608P | 2008-02-19 | 2008-02-19 | |
US61/029,915 | 2008-02-19 | ||
US61/029,913 | 2008-02-19 | ||
US61/029,916 | 2008-02-19 | ||
US5092108P | 2008-05-06 | 2008-05-06 | |
US61/050,921 | 2008-05-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009105507A2 WO2009105507A2 (fr) | 2009-08-27 |
WO2009105507A3 true WO2009105507A3 (fr) | 2010-01-14 |
Family
ID=40986169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/034461 WO2009105507A2 (fr) | 2008-02-19 | 2009-02-19 | Béloxépine, ses énantiomères et certains de leurs analogues convenant au traitement de la douleur |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2285818A4 (fr) |
JP (1) | JP2011512414A (fr) |
KR (1) | KR20100137473A (fr) |
CN (1) | CN102007139A (fr) |
AU (1) | AU2009215541A1 (fr) |
BR (1) | BRPI0908098A2 (fr) |
CA (1) | CA2715192A1 (fr) |
IL (1) | IL207668A0 (fr) |
MX (1) | MX2010009110A (fr) |
NZ (2) | NZ587896A (fr) |
WO (1) | WO2009105507A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090233959A1 (en) | 2008-02-19 | 2009-09-17 | Adolor Corporation | Beloxepin and analogs for the treatment of pain |
EA201992474A3 (ru) | 2015-02-25 | 2020-05-31 | Дзе Риджентс Оф Дзе Юниверсити Оф Калифорниа | Агонисты 5ht для лечения нарушений |
CN106243096B (zh) * | 2016-07-29 | 2019-11-29 | 上海璃道医药科技有限公司 | 三环类药物的新用途 |
US10966938B2 (en) | 2019-01-04 | 2021-04-06 | Jonand4, Llc | Composition and method for preventing or treating hangover symptoms |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997044326A1 (fr) * | 1996-05-23 | 1997-11-27 | F. Hoffmann-La Roche Ag | Derives d'aryl pyrimidine |
WO2001062341A2 (fr) * | 2000-02-22 | 2001-08-30 | Knoll Gmbh | Agents therapeutiques |
WO2004052461A1 (fr) * | 2002-12-11 | 2004-06-24 | Pharmacia & Upjohn Company Llc | Traitement combine de troubles deficitaires de l'attention avec hyperactivite |
WO2005042501A1 (fr) * | 2003-11-03 | 2005-05-12 | Warner-Lambert Company Llc | Nouveaux inhibiteurs du recaptage de la norepinephrine pour le traitement des troubles du systeme nerveux central |
WO2006065600A2 (fr) * | 2004-12-13 | 2006-06-22 | Arena Pharmaceuticals, Inc. | Derives de n-biaryl et de n-arylheteroaryl piperazine servant de modulateurs du recepteur 5ht2c utilises pour le traitement de troubles associes a celui-ci |
WO2006079637A1 (fr) * | 2005-01-27 | 2006-08-03 | Janssen Pharmaceutica N.V. | Derives heterocycliques tetracycliques de tetrahydrofuranne en tant qu'inhibiteurs de 5ht2 dans le traitement de troubles du systeme nerveux central |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
WO2007041258A1 (fr) * | 2005-09-29 | 2007-04-12 | Wyeth | Derives de benzothiadiazolyphenylalkylamine utilises dans le traitement d'etats pathologiques ameliores par le recaptage de la monoamine |
WO2007112453A2 (fr) * | 2006-03-28 | 2007-10-04 | Neopro Labs, Llc | Méthodes et compositions pour traiter des conditions |
WO2007129111A1 (fr) * | 2006-05-03 | 2007-11-15 | Merck Sharp & Dohme Limited | Dérivés de diazépine en tant qu'antagonistes de 5-ht2a |
WO2007142923A1 (fr) * | 2006-05-31 | 2007-12-13 | Avigen, Inc. | Inhibiteurs mif destinés au traitement d'une douleur névropathique et des syndromes associés |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE62754B1 (en) * | 1988-08-26 | 1995-02-22 | Akzo Nv | Tetracyclic antidepressants |
US5663178A (en) | 1995-02-06 | 1997-09-02 | Eli Lilly And Company | Tetrahydro-beta carbolines |
US5952331A (en) | 1996-05-23 | 1999-09-14 | Syntex (Usa) Inc. | Aryl pyrimidine derivatives |
GB0019950D0 (en) | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
-
2009
- 2009-02-19 KR KR1020107021010A patent/KR20100137473A/ko not_active Application Discontinuation
- 2009-02-19 CN CN2009801138213A patent/CN102007139A/zh active Pending
- 2009-02-19 JP JP2010547737A patent/JP2011512414A/ja not_active Withdrawn
- 2009-02-19 EP EP09712730A patent/EP2285818A4/fr not_active Withdrawn
- 2009-02-19 BR BRPI0908098-8A patent/BRPI0908098A2/pt not_active IP Right Cessation
- 2009-02-19 MX MX2010009110A patent/MX2010009110A/es not_active Application Discontinuation
- 2009-02-19 WO PCT/US2009/034461 patent/WO2009105507A2/fr active Application Filing
- 2009-02-19 NZ NZ587896A patent/NZ587896A/en not_active IP Right Cessation
- 2009-02-19 AU AU2009215541A patent/AU2009215541A1/en not_active Abandoned
- 2009-02-19 CA CA2715192A patent/CA2715192A1/fr not_active Abandoned
- 2009-02-19 NZ NZ594937A patent/NZ594937A/xx not_active Application Discontinuation
-
2010
- 2010-08-18 IL IL207668A patent/IL207668A0/en unknown
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997044326A1 (fr) * | 1996-05-23 | 1997-11-27 | F. Hoffmann-La Roche Ag | Derives d'aryl pyrimidine |
WO2001062341A2 (fr) * | 2000-02-22 | 2001-08-30 | Knoll Gmbh | Agents therapeutiques |
WO2004052461A1 (fr) * | 2002-12-11 | 2004-06-24 | Pharmacia & Upjohn Company Llc | Traitement combine de troubles deficitaires de l'attention avec hyperactivite |
WO2005042501A1 (fr) * | 2003-11-03 | 2005-05-12 | Warner-Lambert Company Llc | Nouveaux inhibiteurs du recaptage de la norepinephrine pour le traitement des troubles du systeme nerveux central |
WO2006065600A2 (fr) * | 2004-12-13 | 2006-06-22 | Arena Pharmaceuticals, Inc. | Derives de n-biaryl et de n-arylheteroaryl piperazine servant de modulateurs du recepteur 5ht2c utilises pour le traitement de troubles associes a celui-ci |
WO2006079637A1 (fr) * | 2005-01-27 | 2006-08-03 | Janssen Pharmaceutica N.V. | Derives heterocycliques tetracycliques de tetrahydrofuranne en tant qu'inhibiteurs de 5ht2 dans le traitement de troubles du systeme nerveux central |
US20060293309A1 (en) * | 2005-03-28 | 2006-12-28 | Dynogen Pharmaceuticals, Inc. | Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors |
WO2007041258A1 (fr) * | 2005-09-29 | 2007-04-12 | Wyeth | Derives de benzothiadiazolyphenylalkylamine utilises dans le traitement d'etats pathologiques ameliores par le recaptage de la monoamine |
WO2007112453A2 (fr) * | 2006-03-28 | 2007-10-04 | Neopro Labs, Llc | Méthodes et compositions pour traiter des conditions |
WO2007129111A1 (fr) * | 2006-05-03 | 2007-11-15 | Merck Sharp & Dohme Limited | Dérivés de diazépine en tant qu'antagonistes de 5-ht2a |
WO2007142923A1 (fr) * | 2006-05-31 | 2007-12-13 | Avigen, Inc. | Inhibiteurs mif destinés au traitement d'une douleur névropathique et des syndromes associés |
Non-Patent Citations (1)
Title |
---|
PAANAKKER, J.E. ET AL.: "Validation of an LC-MS assay for the quantification of the enantiomers of Org 4428 in human plasma", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS., vol. 16, 28 October 1998 (1998-10-28), pages 981 - 989 * |
Also Published As
Publication number | Publication date |
---|---|
NZ594937A (en) | 2013-03-28 |
JP2011512414A (ja) | 2011-04-21 |
CN102007139A (zh) | 2011-04-06 |
KR20100137473A (ko) | 2010-12-30 |
BRPI0908098A2 (pt) | 2015-08-18 |
IL207668A0 (en) | 2010-12-30 |
MX2010009110A (es) | 2010-11-30 |
CA2715192A1 (fr) | 2009-08-27 |
AU2009215541A1 (en) | 2009-08-27 |
NZ587896A (en) | 2011-09-30 |
EP2285818A2 (fr) | 2011-02-23 |
EP2285818A4 (fr) | 2011-08-17 |
WO2009105507A2 (fr) | 2009-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2011007930A (es) | Conjugados de insulina cristalina. | |
BRPI0814941A2 (pt) | Composição de tratamentode semente, e, método de tratamento de semente. | |
EP2260109A4 (fr) | Procédés et compositions à base de micro-arn permettant de diagnostiquer, de pronostiquer et de traiter des troubles liés à la prostate | |
WO2009129246A3 (fr) | Compositions et leurs procédés de préparation et d'utilisation | |
MX2014011134A (es) | Compuestos de carbamato y preparacion y uso de los mismos. | |
MY172372A (en) | Compositions and methods for lowering triglycerides | |
WO2008063842A3 (fr) | Méthodes de traitement de la douleur neuroapathique au moyen d'agonistes de ppar-gamma | |
MX2010007490A (es) | Preparacion de derivados de sulfamida. | |
EP2337535A4 (fr) | Systèmes, dispositifs et procédés pour le traitement d'un acouphène | |
IL211313A0 (en) | Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies | |
WO2011047091A9 (fr) | Méthodes de traitement de lésions traumatiques du cerveau | |
WO2010088450A3 (fr) | Procédés de traitement de maladies associées à la modulation de serca | |
EA201170672A1 (ru) | Соединения, пригодные для лечения целлюлита | |
WO2012017321A3 (fr) | Traitement de la dyslipidémie | |
GB2465814B (en) | Method,composition and device for the treatment of enzymes and saccharides disorders | |
EP2207555A4 (fr) | Nouveaux composés pour le traitement ou l'atténuation des oedèmes, et leurs méthodes d'utilisation | |
WO2009102789A3 (fr) | Utilisation d'agonistes de rxr pour le traitement de l'arthrose | |
MX2009009693A (es) | Metodos para activar irs-1 y akt. | |
WO2009120368A3 (fr) | Traitement de lésions cérébrales utilisant des cellules sanguines de cordon ombilical | |
WO2009105507A3 (fr) | Béloxépine, ses énantiomères et certains de leurs analogues convenant au traitement de la douleur | |
WO2009126695A3 (fr) | Procédé de traitement ou de prévention de troubles de kératoconjonctivite sèche utilisant des alkylamino-polyhydroxyalcanes | |
WO2012082942A3 (fr) | Analogues de neuropeptides, compositions et procédés pour le traitement de la douleur | |
WO2008085927A3 (fr) | Procédés, compositions et kits destinés au traitement de la douleur | |
WO2011084523A3 (fr) | Compositions à base d'ulk1, inhibiteurs, dépistage et procédés d'utilisation | |
EP2246533A4 (fr) | Élément coulissant et procédé pour traiter la surface de l'élément coulissant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980113821.3 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09712730 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 207668 Country of ref document: IL Ref document number: 2715192 Country of ref document: CA Ref document number: 2010547737 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009215541 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009712730 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 587896 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1952/MUMNP/2010 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2009215541 Country of ref document: AU Date of ref document: 20090219 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20107021010 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: PI0908098 Country of ref document: BR Kind code of ref document: A2 Effective date: 20100819 |